Yoshindo Bags Biocon Biosimilars Rights In First Post-Lupin Deal

Yoshindo To Market Biocon’s Ustekinumab And Denosumab In Japan Once Approved

 
• By Rosalind Rei
  
Vial and syringe laid out on top of a Japanese flag
• Source: Shutterstock

More from Deals

More from Business